Melatonin in mitochondrial dysfunction and related disorders
Abstract: Mitochondrial dysfunction is considered one of the major causative factors in the aging process, ischemia/reperfusion (I/R), septic shock, and neurodegenerative disorders like Parkinson’s disease (PD), Alzheimer’s disease (AD), and Huntington’s disease (HD). Increased free radical generation, enhanced mitochondrial inducible nitric oxide (NO) synthase activity, enhancedNOproduction, decreased respiratory complex activity, impaired electron transport system, and opening of mitochondrial permeability transition pore all have been suggested as factors responsible for impaired mitochondrial function. Melatonin, the major hormone of the pineal gland, also acts as an antioxidant and as a regulator of mitochondrial bioenergetic function. Both in vitro and in vivo, melatonin was effective for preventing oxidative stress/nitrosative stress-induced mitochondrial dysfunction seen in experimental models of PD, AD, and HD. In addition, melatonin is known to retard aging and to inhibit the lethal effects of septic shock or I/R lesions by maintaining respiratory complex activities, electron transport chain, and ATP production in mitochondria. Melatonin is selectively taken up by mitochondrial membranes, a function not shared by other antioxidants. Melatonin has thus emerged as a major potential therapeutic tool for treating neurodegenerative disorders such as PD or AD, and for preventing the lethal effects of septic shock or I/R.
Principais autores: | Srinivasan, Venkataramanujan, Spence, David Warren, Pandi Perumal, Seithikurippu R., Brown, Gregory M., Cardinali, Daniel Pedro |
---|---|
Formato: | Artículo biblioteca |
Idioma: | eng eng |
Publicado em: |
Hindawi
2011
|
Assuntos: | MELATONINA, RECEPTORES DE MELATONINA, FUNCION MITOCONDRIAL, ENFERMEDADES NEUROGENERATIVAS, |
Acesso em linha: | https://repositorio.uca.edu.ar/handle/123456789/1656 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Melatonin : clinical perspectives in neurodegeneration
por: Cardinali, Daniel Pedro
Publicado em: (2019) -
Potential use of melatonergic drugs in analgesia : mechanisms of action
por: Srinivasan, Venkataramanujan, et al.
Publicado em: (2010) -
Melatonin as a therapeutic tool in ophtalmology : implication for glaucoma and uveitis
por: Rosenstein, Ruth E., et al.
Publicado em: (2010) -
Malaria : therapeutic implications of melatonin
por: Srinivasan, Venkataramanujan, et al.
Publicado em: (2010) -
Melatonin in chagas disease : possible therapeutic value
por: Cardinali, Daniel Pedro, et al.
Publicado em: (2011)